Will give Rs 10 lakh for eliminating "pro-Pakistan" sloganeers: Sri Ram Sena leader

Bengaluru, Jan 30: Karnataka Chief Minister B S Yediyurappa, who reached the national capital on Thursday, said he will discuss the much-awaited Ministry expansion with the BJP high command.

"It's been long that I visited Delhi. I will meet the party national president J P Nadda and Home Minister Amit Shah and take their suggestions on the cabinet expansion," Yediyurappa told reporters.

The chief minister said he will also call on Finance Minister Nirmala Sitharaman and Petroleum Minister Dharmendra Pradhan and discuss about development issues related to Karnataka.

Yediyurappa has been anxiously waiting for the high command's nod to expand his ministry amid intense lobbying by the aspirants.

Opposition parties have been critical of the BJP and Yediyurappa over the delay in cabinet expansion, alleging that he was weak and that the administration had collapsed.

As the chief minister has already made it clear that 11 of the disqualified JDS-Congress MLAs who got re-elected in the bypolls on BJP tickets will be made ministers, lobbying has been on in the party for the remaining ministerial berths.

Currently, there are 18 Ministers, including the chief minister in the cabinet that has a sanctioned strength of 34. Sixteen berths are vacant.

Bengaluru, Jun 16: Former prime minister H D Deve Gowda on Tuesday termed as 'disturbing' the violent clash between Indian and Chinese troops in Galwan Valley and said the government should offer a clearer picture to the nation on the border issue.

He sought to know as to how Indian soldiers lost their lives during a de-escalation process and said Prime Minister Narendra Modi and Defence Minister Rajnath Singh should come out with a clearer picture.

"Reports coming from #GalwanValley are disturbing. Why did our soldiers lose their lives during a de-escalation process? In national interest, the PM and RM should offer a clearer picture to the nation on the border issue with the Chinese. #LADAKHSTANDOFF," Gowda tweeted. An Indian Army officer and two soldiers were killed during the confrontation with Chinese troops in the Galwan Valley in eastern Ladakh on Monday night, the first such incident in the last 45 years that reflected massive escalation in the five- week border row.

The Army said India lost an officer and two soldiers during the violent face-off, while there were casualties on the Chinese side as well.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.